this page only  
Join BIO   |   Member Directory   |    Contact BIO    
Biotechnology Industry Organization
Bio Photo

Home
About BIO
Members.BIO.org
BIO News Online
BIO Bulletins
Suggestion Box
Membership Directory
BIO Videos
News & Media
National Issues
Health Care
Food & Agriculture
Industrial & Environmental
Bioethics
Intellectual Property
Regulatory
Tax & Financial
State & Local Issues
State by State Initiatives
Letters, Testimony & Comments
Speeches & Publications
Industry At-a-Glance
Conferences & Events
Business & Finance


Sunday, May 18, 2008

Health Care

highlightshealth care
food & agriculturebioethics

Submission Regarding Implementation Date of California e-Pedigree Laws (January 9, 2008)
BIO letter to the California State Board Pharmacy
Read the letter (272 KB PDF)

Letter Regarding Massachusetts Universal Coverage Mandate (March 15, 2007)
BIO letter to the Commonwealth Health Insurance Connector Authority regarding the inclusion of prescription drugs for Minimum Creditable Coverage (MCC) under the Commonwealth Choice program.
Read the letter (104 KB PDF)

Letter to the Virginia Senate Rules Committee (January 26, 2007)
Regarding SJR 397: The resolution call for the collection of data on current costs of insulin and human growth hormone in the Commonwealth, and requests FDA to issue guidelines to facilitate the production of follow-on biologics to treat diabetes and other diseases.
Read the letter (112 KB PDF)

Kentucky Medicaid (KyHealth Choices) Cost-Sharing Letter (August 30, 2006)
Read the letter (112 KB PDF)

Letter Opposing California SB 452 (August 17, 2006)
Read the letter (110 KB PDF)

Letter Supporting Florida HB 371 (May 15, 2006)
Read the letter (64 KB PDF)

Letter Opposing New Hampsire House Bill 1346 (April 19, 2006)
Read the letter (49 KB PDF)

BIO Letter to D.C. Councilmember Catania
Opposing Leg. No. B16-0114: The bill authorizes the compulsory licensing of prescription drugs that are still under patent by drug manufacturers. (April 18, 2005)
Read the letter. (22 KB PDF)

Comments on Proposed Guide to Vermont’s Pharmaceutical Marketer Price Disclosure Law (November 15, 2004)
Read the letter. (460 KB PDF)

BIO Letter to California Senator Ortiz
Opposing AB 1957: The bill authorizes the establishment of a state-sponsored Web site to facilitate the purchase of prescription drugs from Canadian sources. (June 15, 2004)
Read the letter. (159 KB PDF)

BIO Letter to California Assemblywoman Cohn
Opposing SB 1144 & SB 1333: The bills authorize the purchase of prescription drugs from Canadian sources. (June 3, 2004)
Read the letter. (131 KB PDF)

BIO Letter to Orange County, California Supervisor Smith
Opposing the county's exploration of a Canadian importation program (May. 19, 2004). Read the letter.

BIO Letter to Seattle City Councilmember Steinbrueck
Opposing the city’s exploration of a Canadian importation program (Mar. 30, 2004).
Read the letter.

BIO Letter to Rhode Island Sen. Roberts
Opposing SB 2160 & HB 7230: The bills propose permitting Canadian pharmacies to import prescription drugs into the state (May 6, 2004).
Read the letter.

BIO Testimony Opposing Maryland SB 167
SB 167 proposes a Canadian mail order plan for prescription drugs (Mar. 3, 2004).
Read the testimony.

BIO Letter to Sen. Prezioso
Opposing West Virginia HB 4084 (Feb. 5, 2004).
Read the letter.

BIO Letter to Montgomery County Maryland Councilmember Perez
Opposing County Importation Proposal (Nov. 4, 2003).
Read the letter.

BIO Letter to Virginia Secretary of Commerce & Trade
on Proposed PDL (Oct. 15, 2003).
Read the letter.

BIO Letter to California Sen. Alpert
Opposing AB 262: The bill makes it unlawful to access information related to physician prescribing information from pharmacies. (May 25, 2004).
Read the letter.

BIO Prior Authorization Safeguards (July 2003).




© 2008 | Biotechnology Industry Organization | 1201 Maryland Ave., SW, Ste. 900 | Washington, D.C. 20024